Neurogene Inc.
NASDAQ:NGNEBiotechnology
Healthcare
$23.10 +2.47%
+$0.76 today
- Market cap
- $365.03M
- Beta
- 2.04
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$4.42
52W Low $14.65High $37.27
Volume 0.28M
Average 0.16M
Private 5-step workspace
Build a NGNE investment thesis
Turn Neurogene Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.